InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Tregoning Kathleen. Director active across 2 companies, notably Spero Therapeutics, Inc.. Cumulatively, 6 reports have been logged. History available since 15 September 2022. The latest transaction was disclosed on 29 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations